CARA THERAPEUTICS, INC.

(CARA)
  Bericht
Verzögert Nasdaq  -  22:00 27.06.2022
9.680 USD   +3.09%
06.06.Amarin ernennt Tom Reilly zum Finanzchef
MT
06.06.Cara Therapeutics CFO Thomas Reilly tritt zurück
MT
09.05.Earnings Flash (CARA) CARA THERAPEUTICS erzielt in Q1 einen Umsatz von $4,8 Mio.
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über CARA THERAPEUTICS, INC.
07.06.CARA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
06.06.Amarin Names Tom Reilly Finance Chief
06.06.Cara Therapeutics CFO Thomas Reilly Resigns
03.06.CARA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
03.06.Cara Therapeutics, Inc. Announces Resignation of Thomas Reilly as Chief Financial Offic..
17.05.Cara Therapeutics to Present at Upcoming Investor Conferences
10.05.TRANSCRIPT : Cara Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conferenc..
09.05.TRANSCRIPT : Cara Therapeutics, Inc., Q1 2022 Earnings Call, May 09, 2022
09.05.CARA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
09.05.CARA : Q1 Earnings Snapshot
09.05.Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $4.8M
09.05.Cara Therapeutics Reports First Quarter 2022 Financial Results
09.05.Cara Therapeutics Reports First Quarter 2022 Financial Results
09.05.Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
03.05.Cara Therapeutics to Present at May Investor Conferences
02.05.Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
29.04.Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
28.04.Cara Therapeutics Wins EC Marketing Authorization for Kapruvia to Treat Chronic Kidney ..
28.04.VIFOR : le Kapruvia approuvé par la Commission européenne
28.04.Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruri..
28.04.Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. Announces the Eur..
05.04.Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
04.04.Cara Therapeutics Announces Biomarker Data from KALM-1 and KALM-2 Trials of KORSUVA&tra..
29.03.Cara Therapeutics Announces Oral KORSUVA (difelikefalin) Improves Itch and Inflammatory..
28.03.Cara Therapeutics Says Phase 2 Data of Drug Candidate for Atopic Dermatitis-Related Pru..
28.03.Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Improves Itch and Infla..
28.03.Cara Therapeutics, Inc Announces Oral KORSUVA™ (difelikefalin) Improves Itch and I..
12.03.CARA THERAPEUTICS : 2022 R&D Day Presentation
11.03.CARA THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (for..
11.03.TRANSCRIPT : Cara Therapeutics, Inc. - Special Call
09.03.Cara Therapeutics Announces Oral KORSUVA (difelikefalin) Data Selected for Late-Breakin..
08.03.Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-..
02.03.Cara Therapeutics Files for Up to $300 Million Mixed-Securities Shelf
02.03.Cara Therapeutics Swings to Q4 Loss, Missing Estimates -- Shares Drop 6% After Hours
01.03.CARA THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
01.03.TRANSCRIPT : Cara Therapeutics, Inc., Q4 2021 Earnings Call, Mar 01, 2022
01.03.CARA : Q4 Earnings Snapshot
01.03.CARA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
01.03.Cara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2..
01.03.Earnings Flash (CARA) CARA THERAPEUTICS Posts Q4 Revenue $821,000, vs. Street Est of $1..
01.03.Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
01.03.Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
01.03.Cara Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December ..
28.02.Vifor Pharma Drug Gets Backing from European Medicines Agency Committee
28.02.VFMCRP - Kapruvia receives positive CHMP opinion for the treatment of moderate-to-sever..
28.02.BOURSE ZURICH : le SMI ancré dans le rouge, après les sanctions contre la Russie
28.02.BOURSE ZURICH : ouverture dans le rouge, sous le signe du conflit russo-ukrainien
28.02.BOURSE ZURICH : la guerre en Ukraine continue de faire trembler les marchés
28.02.VIFOR : recommandation européenne pour l'homologation du Kapruvia
25.02.Cara Therapeutics, Vifor Say EMA Panel Backs Approval of Kapruvia for Itchy Skin in Hem..
25.02.Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe prurit..
25.02.Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. Announce CHMP Rec..
22.02.Cara Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results on Ma..
21.02.Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
18.02.Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
11.01.Cara Therapeutics Announces Difelikefalin (KORSUVA) Injection Achieves Positive Topline..
10.01.TRANSCRIPT : Cara Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conferenc..
10.01.Cara Therapeutics Says Late-Stage Trial in Japan of Pruritus Treatment Meets Clinical E..
10.01.Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive ..
10.01.Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive T..
10.01.CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Dis..
03.01.Cara Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021CARA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
2021Cara Therapeutics' Korsuva Injection Receives TDAPA Reimbursement
2021CARA THERAPEUTICS : Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection..
2021CARA THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and..
2021Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injectio..
2021SWK Holdings Subsidiary Gets $5 Million Milestone Payment From Cara Therapeutics
2021Cara Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer..
2021Cara Therapeutics to Present at Upcoming Investor Conferences
2021Cara Therapeutics Reports Narrower Q3 Loss
2021TRANSCRIPT : Cara Therapeutics, Inc., Q3 2021 Earnings Call, Nov 08, 2021
2021Cara Therapeutics Reports Third Quarter 2021 Financial Results - Form 8-K
2021CARA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
2021CARA : Q3 Earnings Snapshot
1  2  3  4  5  6  7  8  9Weiter
Anstehende Termine für CARA THERAPEUTICS, INC.